Galecto (GLTO)
(Delayed Data from NSDQ)
$0.52 USD
+0.03 (7.15%)
Updated Aug 9, 2024 03:59 PM ET
After-Market: $0.51 -0.01 (-1.92%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum F VGM
Galecto, Inc. (GLTO) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$5.50 | $9.00 | $2.00 | 1,022.45% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for Galecto, Inc. comes to $5.50. The forecasts range from a low of $2.00 to a high of $9.00. The average price target represents an increase of 1% from the last closing price of $0.49.
Analyst Price Targets (2 )
Broker Rating
Galecto, Inc. currently has an average brokerage recommendation (ABR) of 2.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by three brokerage firms. The current ABR compares to an ABR of 2.33 a month ago based on three recommendations.
Of the three recommendations deriving the current ABR, one is Strong Buy, representing 33.33% of all recommendations. A month ago, Strong Buy represented 33.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.33 | 2.33 | 2.33 | 2.33 | 2.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/10/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/16/2024 | SVB Securities | Thomas J Smith | Hold | Hold |
5/1/2024 | H.C. Wainwright & Co. | Raghuram Selvaraju | Not Available | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.33 |
ABR (Last week) | 2.33 |
# of Recs in ABR | 3 |
Average Target Price | $5.50 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 75 of 253 |
Current Quarter EPS Est: | -0.32 |